Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Beth Woods

Showing results (31-40 of 45) with videos related to

Pageof 5
Sort By:
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|October 31, 2025
Estimating the Shares of the Value of Branded Pharmaceuticals Accruing to Manufacturers and to Patients in the Thai Healthcare SystemJessica M Ochalek, Beth Woods, Lapad Pongcharoenyong, et al.
Journal of Medical Economics|July 30, 2016
Brentuximab vedotin in relapsed/refractory Hodgkin lymphoma post-autologous stem cell transplant: a cost-effectiveness analysis in ScotlandChristopher Parker, Beth Woods, James Eaton, et al.
Atherosclerosis|January 15, 2023
How does cholesterol burden change the case for investing in familial hypercholesterolaemia? A cost-effectiveness analysisRita Faria, Pedro Saramago, Edward Cox, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 12, 2018
Simulation Modeling and Metamodeling to Inform National and International HIV Policies for Children and AdolescentsAndrea Ciaranello, Annette H Sohn, Intira Jeannie Collins, et al.
Heart (British Cardiac Society)|July 15, 2016
Cost-effectiveness of implantable cardiac devices in patients with systolic heart failureStuart Mealing, Beth Woods, Neil Hawkins, et al.
Plos One|March 8, 2017
Cost-effectiveness of adjunct non-pharmacological interventions for osteoarthritis of the kneeBeth Woods, Andrea Manca, Helen Weatherly, et al.
Atherosclerosis|September 29, 2024
Efficacy and safety of statins, ezetimibe and statins-ezetimibe therapies for children and adolescents with heterozygous familial hypercholesterolaemia: Systematic review, pairwise and network meta-analyses of randomised controlled trialsAlexis Llewellyn, Mark Simmonds, David Marshall, et al.
BMJ Open|January 8, 2026
Economic evaluation protocol for the PRevention Of sudden cardiac death aFter myocardial Infarction by Defibrillator implantation: the PROFID EHRA trialYirui Qian, Carlos Rojas Roque, Beth Woods, et al.
Communications Medicine|October 11, 2024
Antimicrobial drug pricingAvaneesh Kumar Pandey, Nusrat Shafiq, Ashish Kumar Kakkar, et al.
Health Technology Assessment (Winchester, England)|June 28, 2024
Cefiderocol for treating severe aerobic Gram-negative bacterial infections: technology evaluation to inform a novel subscription-style payment modelBeth Woods, Laetitia Schmitt, Dina Jankovic, et al.
Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|October 31, 2025
Estimating the Shares of the Value of Branded Pharmaceuticals Accruing to Manufacturers and to Patients in the Thai Healthcare SystemJessica M Ochalek, Beth Woods, Lapad Pongcharoenyong, et al.
Journal of Medical Economics|July 30, 2016
Brentuximab vedotin in relapsed/refractory Hodgkin lymphoma post-autologous stem cell transplant: a cost-effectiveness analysis in ScotlandChristopher Parker, Beth Woods, James Eaton, et al.
Atherosclerosis|January 15, 2023
How does cholesterol burden change the case for investing in familial hypercholesterolaemia? A cost-effectiveness analysisRita Faria, Pedro Saramago, Edward Cox, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 12, 2018
Simulation Modeling and Metamodeling to Inform National and International HIV Policies for Children and AdolescentsAndrea Ciaranello, Annette H Sohn, Intira Jeannie Collins, et al.
Heart (British Cardiac Society)|July 15, 2016
Cost-effectiveness of implantable cardiac devices in patients with systolic heart failureStuart Mealing, Beth Woods, Neil Hawkins, et al.
Plos One|March 8, 2017
Cost-effectiveness of adjunct non-pharmacological interventions for osteoarthritis of the kneeBeth Woods, Andrea Manca, Helen Weatherly, et al.
Atherosclerosis|September 29, 2024
Efficacy and safety of statins, ezetimibe and statins-ezetimibe therapies for children and adolescents with heterozygous familial hypercholesterolaemia: Systematic review, pairwise and network meta-analyses of randomised controlled trialsAlexis Llewellyn, Mark Simmonds, David Marshall, et al.
BMJ Open|January 8, 2026
Economic evaluation protocol for the PRevention Of sudden cardiac death aFter myocardial Infarction by Defibrillator implantation: the PROFID EHRA trialYirui Qian, Carlos Rojas Roque, Beth Woods, et al.
Communications Medicine|October 11, 2024
Antimicrobial drug pricingAvaneesh Kumar Pandey, Nusrat Shafiq, Ashish Kumar Kakkar, et al.
Health Technology Assessment (Winchester, England)|June 28, 2024
Cefiderocol for treating severe aerobic Gram-negative bacterial infections: technology evaluation to inform a novel subscription-style payment modelBeth Woods, Laetitia Schmitt, Dina Jankovic, et al.
Pageof 5